Skip to main content
UCL Logo Navigate back to homepage

Main navigation

  • Home
  • Study

    Study

    • Study at UCL
    • Prospective students
    • Current students
    • Accommodation
    • Careers
    • Doctoral School
    • Immigration and visas
    • Student finances
    • Support and wellbeing
  • Research

    Research

    • Research at UCL
    • Engage with us
    • Explore our Research
    • Initiatives and networks
    • Research news
  • Engage

    Engage

    • Engage with UCL
    • Alumni
    • Business partnerships and collaboration
    • Global engagement
    • News and Media relations
    • Policy and political engagement
    • Schools and priority groups
    • Give to UCL
  • About

    About

    • About UCL
    • Who we are
    • Faculties
    • Governance
    • President and Provost
    • Strategy
    • UCL's Bicentenary
  • UCL Logo Active parent page: Faculty of Medical Sciences
    • Study
    • Research
    • Divisions and Institutes
    • Events
    • About
    • Active parent page: News
    • Contacts

Professor Alimuddin Zumla receives knighthood

Professor Zumla received a knighthood for his services to public health.

26 June 2017

UCL Portico

Breadcrumb trail

  • Faculty of Medical Sciences

Faculty menu

  • Study
  • Research
  • Divisions and Institutes
  • Events
  • About
  • Current page: News
  • Contacts

Breadcrumb trail

  • Faculty of Medical Sciences
  • Professor Alimuddin Zumla receives knighthood

Professor Sir Alimuddin (Ali) Zumla, has been honoured by Her Majesty the Queen in her 2017 Birthday Honours list with a knighthood (KBE) for his services to public health and protection from infectious diseases.

Professor Zumla was made a Knight Bachelor of The Most Excellent Order (KBE), conferring the title of ‘Sir’ and is the highest civilian honour accorded by the Queen.

Links

  • Source: UCL News
  • Read UNZA-UCLMS press release

Highlights in Medical Sciences

Groundbreaking bowel cancer trial follow-up shows zero relapses
close up view of a mans arm while having an IV immunoglobulin infusion at hospital

Research

Groundbreaking bowel cancer trial follow-up shows zero relapses

Patients with a specific bowel cancer who were given short-course immunotherapy before surgery, instead of post-op chemotherapy, remained cancer-free after nearly three years of follow-up.

Drug to treat aggressive leukaemia approved for use in adults
Fluorescence microscopy image of immune cells, showing blue-stained nuclei surrounded by green cell membranes with red marker signals indicating specific proteins or activity within the cells.

Research

Drug to treat aggressive leukaemia approved for use in adults

Adult patients with aggressive leukaemia will soon be able to receive a breakthrough immunotherapy, developed by UCL researchers, on the NHS after approval by NICE.

Millions could benefit from faster prostate cancer scan
healthy prostate scan

Research

Millions could benefit from faster prostate cancer scan

Results of the PRIME trial involving UCL Medical Sciences researchers have found that a quicker, cheaper MRI scan was just as accurate at diagnosing prostate cancer as the current 30-40 minute scan.

UCL footer

Visit

  • Bloomsbury Theatre and Studio
  • Library, Museums and Collections
  • UCL Maps
  • UCL Shop
  • Contact UCL

Students

  • Accommodation
  • Current Students
  • Moodle
  • Students' Union

Staff

  • Inside UCL
  • Staff Intranet
  • Work at UCL
  • Human Resources
UCL Logo

University College London

Gower Street, London, WC1E 6BT

Telephone: +44 (0) 20 7679 2000

UCL social media menu

  • Link to Instagram
  • Link to LinkedIn
  • Link to Youtube
  • Link to TikTok
  • Link to Facebook
  • Link to Bluesky
  • Link to Threads
  • Link to Soundcloud
Here, it can happen.
Back to top

Essential

  • Disclaimer
  • Freedom of Information
  • Accessibility
  • Cookies
  • Privacy
  • Slavery statement
  • Log in

© 2026 UCL